Singapore markets closed
  • Straits Times Index

    3,270.98
    -11.90 (-0.36%)
     
  • Nikkei

    27,999.96
    -249.28 (-0.88%)
     
  • Hang Seng

    20,003.44
    -42.33 (-0.21%)
     
  • FTSE 100

    7,486.08
    +3.71 (+0.05%)
     
  • BTC-USD

    23,111.81
    -1,074.69 (-4.44%)
     
  • CMC Crypto 200

    535.88
    -21.47 (-3.85%)
     
  • S&P 500

    4,131.57
    -8.49 (-0.21%)
     
  • Dow

    32,847.03
    +14.49 (+0.04%)
     
  • Nasdaq

    12,520.32
    -124.14 (-0.98%)
     
  • Gold

    1,807.90
    +2.70 (+0.15%)
     
  • Crude Oil

    91.43
    +0.67 (+0.74%)
     
  • 10-Yr Bond

    2.7830
    +0.0180 (+0.65%)
     
  • FTSE Bursa Malaysia

    1,497.68
    +1.65 (+0.11%)
     
  • Jakarta Composite Index

    7,102.88
    +16.03 (+0.23%)
     
  • PSE Index

    6,468.97
    +34.73 (+0.54%)
     

Digital Diabetes Management Global Market Report 2021: Market is Expected to Reach $17.09 Billion in 2025 at a CAGR of 23% - Forecast to 2030 - ResearchAndMarkets.com

·4-min read

DUBLIN, December 06, 2021--(BUSINESS WIRE)--The "Digital Diabetes Management Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

The global digital diabetes management market is expected to grow from $6.17 billion in 2020 to $7.37 billion in 2021 at a compound annual growth rate (CAGR) of 19.4%. The market is expected to reach $17.09 billion in 2025 at a CAGR of 23%.

Major players in the digital diabetes management market are Bayer AG, Medtronic, Roche Diagnostics, Dexcom, Inc., Abbott Laboratories, Ascensia Diabetes Care, Insulet Corporation, B. Braun Melsungen AG, Tandem Diabetes Care, and LifeScan Inc.

The digital diabetes management market consists of sales of digital diabetes management devices and related services. Digital diabetes management includes devices, apps, and software that manage blood glucose levels in the human body. These devices play a vital role in the care of diabetes patients with the management of patient's blood glucose levels and controlling their conditions.

The digital diabetes management market covered in this report is segmented by product and service into devices, application, data management software & platforms, services. It is also segmented by device type into handheld devices, wearable devices and by end user into self/home healthcare, hospitals & specialty diabetes clinics, others.

Data security is a major challenge limiting the growth of the digital diabetes management market. Data safety is necessary to maintain integrity and confidentiality. Lack of accurate flow of information and commands is likely to compromise the function of digital diabetes devices and may put patients or users at the risk of health complications.

According to the Global Application and Network Security Report, 2019-2020 published by Radware, a cybersecurity company, data security and service & application availability are the top two concerns of the healthcare industry.

The increasing prevalence of diabetes is projected to propel the demand for digital diabetes management devices and related services, thereby increasing the demand for the market. Diabetes is a leading cause of death with 30% of loss of life expectancy from diagnosis of diabetes.

According to the European Society of Cardiology's (ESC) global statistics on diabetes published in April 2019, approximately 4 million people under the age of 60 years die from diabetes every year. The prevalence of diabetes for the age group 20-79 years is predicted to increase to 9.9% to reach 628.6 million people with an expected growth of 48% by the end of 2045, globally. Digital diabetes management devices provide continuous care for diabetic patients and provide relevant data for further analysis.

Several companies are increasing attention on developing design-focused and AI-powered connected apps to enhance the user experience, which is gaining significant popularity in the digital diabetes management market. Key companies operating in the digital diabetes management market including OneDrop, Ascencia, and Dario are increasing their focus on developing their products as stylish gadgets rather than medical devices.

Key Topics Covered:

1. Executive Summary

2. Digital Diabetes Management Market Characteristics

3. Digital Diabetes Management Market Trends and Strategies

4. Impact Of COVID-19 On Digital Diabetes Management

5. Digital Diabetes Management Market Size and Growth

5.1. Global Digital Diabetes Management Historic Market, 2015-2020, $ Billion

5.1.1. Drivers Of the Market

5.1.2. Restraints On the Market

5.2. Global Digital Diabetes Management Forecast Market, 2020-2025F, 2030F, $ Billion

5.2.1. Drivers Of the Market

5.2.2. Restraints On the Market

6. Digital Diabetes Management Market Segmentation

6.1. Global Digital Diabetes Management Market, Segmentation by Product & Service, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Devices

  • Application

  • Data Management Software & Platforms

  • Services

6.2. Global Digital Diabetes Management Market, Segmentation by Device Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Handheld Devices

  • Wearable Devices

6.3. Global Digital Diabetes Management Market, Segmentation by End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Self/Home Healthcare

  • Hospitals & Specialty Diabetes Clinics

  • Others

7. Digital Diabetes Management Market Regional and Country Analysis

7.1. Global Digital Diabetes Management Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

7.2. Global Digital Diabetes Management Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Companies Mentioned

  • Bayer AG

  • Medtronic

  • Roche Diagnostics

  • Dexcom Inc.

  • Abbott Laboratories

  • Ascensia Diabetes Care

  • Insulet Corporation

  • B. Braun Melsungen AG

  • Tandem Diabetes Care

  • LifeScan Inc.

  • AgaMatrix

  • Glooko Inc.

  • DarioHealth

  • One Drop

  • Dottli

  • Ypsomed Holding AG

  • ARKRAY Inc

  • ACON Laboratories

  • Becton Dickinson and Company

  • Care innovations

For more information about this report visit https://www.researchandmarkets.com/r/seumzf

View source version on businesswire.com: https://www.businesswire.com/news/home/20211206005723/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting